SR

Seegebagi Rudresh Ashok

Active Director Director DIN 09573195
DIN 09573195 First appointment Apr 2022 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Seegebagi Rudresh Ashok

Data last updated:

Seegebagi Rudresh Ashok is a Director at Vmax Therapeutics Private Limited (since 2022). The company operates in Research & Development.

DIN 09573195
Primary Designation Director
Industry Research & Development
First Appointment 15 Apr 2022
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vmax Therapeutics Private Limited U73100KA2018PTC113667
Director15 Apr 20222018Active

Board colleagues of Seegebagi Rudresh Ashok

NameDINCompanyDesignation
Mahesh Bangalore Nanjundappa08076301Vmax Therapeutics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vmax Therapeutics Private Limited
Premium access

Shareholding and investment profile for Seegebagi Rudresh Ashok

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Seegebagi Rudresh Ashok

Seegebagi Rudresh Ashok currently holds 1 directorship: Vmax Therapeutics Private Limited (Director, since 15 Apr 2022).

Seegebagi Rudresh Ashok was first appointed on 15 Apr 2022 as Director at Vmax Therapeutics Private Limited.

The current boards of Seegebagi Rudresh Ashok's companies include Mahesh Bangalore Nanjundappa (Vmax Therapeutics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available